Breakthrough Alzheimer's Treatment Donanemab
Alzheimer’s Disease—horrible, chronic, debilitating. Can a new medicine give great hope? Did the FDA give an opinion in advance of approval? Dr. Rybacki brings the facts and future meds to your computer in this fascinating new video.
-
Breakthrough Alzheimer's Treatment Donanemab
Alzheimer’s Disease—horrible, chronic, debilitating. Can a new medicine give great hope? Did the FDA give an opinion in advance of approval? Dr. Rybacki brings the facts and future meds to your computer in this fascinating new video.